Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsAdriano Gravina, Federica Perrone, Saverio Cinieri et al.|ESMO Open|2025Cited by 8